These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9609890

  • 1. MR imaging of mammographically detected clustered microcalcifications: is there any value?
    Westerhof JP, Fischer U, Moritz JD, Oestmann JW.
    Radiology; 1998 Jun; 207(3):675-81. PubMed ID: 9609890
    [Abstract] [Full Text] [Related]

  • 2. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O.
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [Abstract] [Full Text] [Related]

  • 3. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA.
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [Abstract] [Full Text] [Related]

  • 4. Three-dimensional MR imaging of mammographically detected suspicious microcalcifications.
    Nakahara H, Namba K, Fukami A, Watanabe R, Maeda Y, Furusawa H, Matsu T, Akiyama F, Nakagawa H, Ifuku H, Nakahara M, Tamura S.
    Breast Cancer; 2001 Jun; 8(2):116-24. PubMed ID: 11342984
    [Abstract] [Full Text] [Related]

  • 5. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [Abstract] [Full Text] [Related]

  • 6. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H, Kessler M, Heuck AF, Bredl T, Perlet C, Künzer I, Lebeau A, Untch M, Reiser M.
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
    Kneeshaw PJ, Lowry M, Manton D, Hubbard A, Drew PJ, Turnbull LW.
    Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
    Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, Sardanelli F, Giuseppetti GM, Simonetti G, Lattanzio V, Del Maschio A.
    AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
    [Abstract] [Full Text] [Related]

  • 9. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [Abstract] [Full Text] [Related]

  • 10. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach.
    Fischer U, Kopka L, Grabbe E.
    Radiology; 1999 Dec; 213(3):881-8. PubMed ID: 10580970
    [Abstract] [Full Text] [Related]

  • 11. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results.
    Lee SG, Orel SG, Woo IJ, Cruz-Jove E, Putt ME, Solin LJ, Czerniecki BJ, Schnall MD.
    Radiology; 2003 Mar; 226(3):773-8. PubMed ID: 12601182
    [Abstract] [Full Text] [Related]

  • 12. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F, Padula S, Dominelli V, Luciani M, Telesca M, Casali V, Kirchin MA, Passariello R, Catalano C.
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Breast microcalcifications studied with 3D contrast-enhanced high-field magnetic resonance imaging: more accuracy in the diagnosis of breast cancer.
    Trecate G, Tess JD, Vergnaghi D, Bergonzi S, De Simone T, Mariani G, Musumeci R.
    Tumori; 2002 Dec; 88(3):224-33. PubMed ID: 12195761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G, Topal U.
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [Abstract] [Full Text] [Related]

  • 18. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F, Catalano C, Padula S, Roselli A, Dominelli V, Cagioli S, Kirchin MA, Pirovano G, Passariello R.
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [Abstract] [Full Text] [Related]

  • 19. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, Untch M, Nathrath WB.
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.